Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Liver Neoplasms 1Head and Neck Neoplasms 1Fibrosis 1

Interventions

Sorafenib 61Bevacizumab 42Oxaliplatin 24Doxorubicin 22Radiosurgery 20Gemcitabine 20Fluorouracil 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17Capecitabine 17lenvatinib 16Cisplatin 16atezolizumab 13Leucovorin 13Radiotherapy 11tremelimumab 10Cyclophosphamide 10Carboplatin 10Irinotecan 9Ipilimumab 9Drug Therapy 9Everolimus 8Cryosurgery 8toripalimab 7fludarabine 7Sunitinib 7Chemotherapy, Adjuvant 7Melphalan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Liver Neoplasms × Enkephalin, Methionine × Clear all
NCT00706576 2017-08-02

Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor

University of Missouri-Columbia

Phase 1 Completed
14 enrolled
Gastrointestinal

Fibrosis, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡